Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 33.23B | 27.47B | 23.91B | 14.70B | 20.07B | 21.08B |
Gross Profit | 9.03B | 7.86B | 5.35B | 3.19B | 4.40B | 3.91B |
EBITDA | 6.09B | 4.88B | 3.43B | 1.69B | 2.76B | 2.55B |
Net Income | 3.84B | 3.02B | 2.10B | 1.17B | 1.64B | 1.46B |
Balance Sheet | ||||||
Total Assets | 41.83B | 44.31B | 38.10B | 35.87B | 32.22B | 37.25B |
Cash, Cash Equivalents and Short-Term Investments | 2.63B | 3.51B | 1.74B | 2.36B | 4.25B | 1.64B |
Total Debt | 8.98B | 7.89B | 7.38B | 8.12B | 5.12B | 11.46B |
Total Liabilities | 15.09B | 16.63B | 12.65B | 12.37B | 9.51B | 15.82B |
Stockholders Equity | 26.50B | 27.44B | 25.24B | 23.32B | 22.56B | 21.39B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 2.44B | -2.17B | -6.12B | 5.36B | 1.52B |
Operating Cash Flow | 0.00 | 2.80B | -2.02B | -6.08B | 5.43B | 2.74B |
Investing Cash Flow | 0.00 | -833.58M | 593.61M | 1.40B | 4.46B | -694.51M |
Financing Cash Flow | 0.00 | -184.03M | 801.30M | 2.79B | -6.98B | -2.25B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | ¥16.10B | 7.58 | 3.61% | 33.00% | 43.41% | ||
80 Outperform | ¥15.99B | 8.23 | 4.56% | 30.20% | 67.98% | ||
77 Outperform | ¥16.11B | 5.23 | 3.37% | 14.89% | 44.60% | ||
75 Outperform | ¥14.33B | 5.95 | 2.57% | 26.52% | 104.37% | ||
70 Outperform | ¥14.02B | 8.58 | 5.91% | -1.02% | -7.65% | ||
69 Neutral | ¥13.37B | 10.94 | ― | 54.73% | 40.02% | ||
63 Neutral | $6.98B | 18.44 | -1.93% | 6.77% | 4.67% | -25.44% |